Michael P. Thomas
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
75
Citations
1,268
Est. group size
~4
Recurring co-author estimate
Active years
59
Publishing since 1967
Typically publishes in teams of ~14 · 4% small-team papers (≤3 authors) · across 9 venues
- Supplementary Figure 1 from Identification of Small Molecules that Sensitize Resistant Tumor Cells to Tumor Necrosis Factor-Family Death Receptors
2023
- Data from Identification of Small Molecules that Sensitize Resistant Tumor Cells to Tumor Necrosis Factor-Family Death Receptors
2023
- Data from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Supplementary Figure 2 from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Supplementary Materials and Methods, Figure Legends from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Supplementary Figure 1 from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Supplementary Figure 5 from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Supplementary Materials and Methods, Figure Legends from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Supplementary Figure 1 from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Supplementary Figure 3 from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Supplementary Figure 2 from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Supplementary Figure 6 from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Abstract 11597: A Rare Cause of an NSTEMI: Left Main Coronary Artery Compression in a Patient With Pulmonary Hypertension
Circulation · 2023
- Data from Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
2023
- Cryoablation for the treatment of ventricular tachycardia in close proximity to coronary arteries
HeartRhythm Case Reports · 2022
- Journal of the American College of Cardiology×5
- Clinical Microbiology and Infection×2
- The American Journal of Cardiology×2
- Circulation Cardiovascular Quality and Outcomes×2
- Circulation×2
- Chandra Bhushan Prasad
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Chao‐Yie Yang
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Aleksas Matvekas
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Aaron D. Krabill
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Chittaranjan Das
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile